📣 Try out the NEW Gateway to Research and let us know what you think.

We're looking for users to test the new service during August and September and share their feedback. Express your interest by completing this short form.

Human CD49a+ Lung Natural Killer Cell Cytotoxicity in Response to Influenza A Virus. (2018)

First Author: Cooper GE

Attributed to: Using MHC class I peptides to modulate NK cell activity, as a basis for immunotherapy funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2018.01671

PubMed Identifier: 30079068

Publication URI: http://europepmc.org/abstract/MED/30079068

Type: Journal Article/Review

Volume: 9

Parent Publication: Frontiers in immunology

ISSN: 1664-3224